Your browser doesn't support javascript.
loading
Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany.
Liu, Jia; Mori, Masahiro; Zimmermann, Hanna; Brandt, Alexander; Havla, Joachim; Tanaka, Satoru; Sugimoto, Kazuo; Oji, Satoru; Uzawa, Akiyuki; Asseyer, Susanna; Cooper, Graham; Jarius, Sven; Bellmann-Strobl, Judith; Ruprecht, Klemens; Siebert, Nadja; Masuda, Hiroki; Uchida, Tomohiko; Ohtani, Ryohei; Nomura, Kyoichi; Meinl, Edgar; Kuempfel, Tania; Paul, Friedemann; Kuwabara, Satoshi.
Afiliação
  • Liu J; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Mori M; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Zimmermann H; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Brandt A; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Havla J; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Tanaka S; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Sugimoto K; Department of Neurology, University of California, Irvine, California, USA.
  • Oji S; Institute of Clinical Neuroimmunology, LMU-Hospital, Ludwig-Maximilians Universiät München, Munich, Germany.
  • Uzawa A; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
  • Asseyer S; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Cooper G; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
  • Jarius S; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Bellmann-Strobl J; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Ruprecht K; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Siebert N; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Masuda H; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Uchida T; Einstein Center for Neurosciences, Berlin, Germany.
  • Ohtani R; Department of Experimental Neurology and Center for Stroke Research, Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Nomura K; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.
  • Meinl E; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Kuempfel T; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Paul F; Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Kuwabara S; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
J Neurol Neurosurg Psychiatry ; 2020 Nov 20.
Article em En | MEDLINE | ID: mdl-33219036
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Neurol Neurosurg Psychiatry Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Neurol Neurosurg Psychiatry Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão